Working… Menu

Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03385239
Recruitment Status : Completed
First Posted : December 28, 2017
Last Update Posted : November 20, 2020
Ionis Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Akcea Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 25, 2019
Actual Study Completion Date : February 25, 2020
Certification/Extension First Submitted : November 19, 2020